Do you know the FDA-directed hemoglobin targets for CKD anemia?
Explore why standard guidelines don't apply to navigate the 10 to 11.5 target range ➡️ https://t.co/yXay59VUWD
#Nephrology#CME#CKD
We’ve had a therapeutic renaissance in #CKD, but residual risk remains high. Discover why we must move faster to implement new therapies and save lives.
Watch the full discussion ➡️ https://t.co/aQzzLMTPNB
#Nephrology#CME
Are your CKD patients experiencing a care mismatch?
Discover how true shared decision-making can align therapies with your patient’s life and goals.
Watch the full discussion ➡️ https://t.co/yXay59VUWD
#Nephrology#CME#CKD
When evaluating new B-cell modulators, experts use the SEAT criteria: Safety, Efficacy, Affordability, and Tolerability.
Learn why these factors are the key to managing a lifelong autoimmune condition ➡️ https://t.co/IjhZjFDU9Y
#Nephrology#CME#IgAN
Anemia management in CKD is more than just a number.
Learn why looking beyond hemoglobin levels to target symptom burdens is a game-changer.
Watch the full discussion ➡️ https://t.co/yXay59VUWD
#Nephrology#CME#CKD
It’s all about the starting point.
Learn how new therapies are targeting "Hit 1", the production of galactose-deficient IgA1, to stop the disease before it starts.
Watch the full discussion ➡️ https://t.co/IjhZjFDU9Y
#Nephrology#CME#IgAN
LIVE in just 60 minutes ➡️ https://t.co/SivPHCpWtC
Tune in to hear Leah Foster Smith and Paul T. Conway discuss "Beating the Blues Together." Learn evidence-based strategies to improve screening and patient communication. See you there!
#Nephrology#CKD#CME
Watch LIVE Tomorrow! ➡️ https://t.co/SivPHCpWtC
Ready to optimize your DD-CKD management? Join us tomorrow to explore shared decision-making strategies and compare conventional treatments with emerging therapies. Don't miss this expert-patient dialogue!
#Nephrology#CKD#CME
Are you seeing the full picture of anemia in your dialysis patients?
Dive into clinical solutions, from screening protocols to the rationale behind HIF-PHIs, through the powerful lens of patient advocacy.
📅 May 12th
🕓 1pm ET
🔗 https://t.co/SivPHCpWtC
#Nephrology#CKD#CME
Anemia in DD-CKD is more than just a lab value, it’s a daily burden.
Join Leah Foster Smith and Patient Advocate Paul T. Conway as they bridge clinical data with lived experience.
📅 May 12th
🕓 1:00pm ET
🔗 https://t.co/SivPHCpWtC
#Nephrology#CKD#CME
Managing IgA Nephropathy is evolving from a "shotgun approach" to precision B-cell modulation.
Learn why targeting the B-cell pathway is a game-changer for kidney stabilization.
Watch the full discussion ➡️ https://t.co/IjhZjFDU9Y
#Nephrology#CME#IgAN
POLL - Urologists wanted a stronger statement from @AmerUrological regarding the SCOTUS decision on abortion. Were you happy with your society's response? https://t.co/ir6PUY5JZy
Join us on Twitter Spaces for straightforward information to equip you with strategies to help you on a journey to better health.
https://t.co/wCourFeqbO